Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Laboratory of Allergy and Precision Medicine, Chengdu Institute of Respiratory Health, Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, 610031, Sichuan, China.
Nat Commun. 2024 Feb 8;15(1):1200. doi: 10.1038/s41467-024-45340-w.
The complexity of the tumor microenvironment (TME) is a crucial factor in lung adenocarcinoma (LUAD) progression. To gain deeper insights into molecular mechanisms of LUAD, we perform an integrative single-cell RNA sequencing (scRNA-seq) data analysis of 377,574 cells from 117 LUAD patient samples. By linking scRNA-seq data with bulk gene expression data, we identify a cluster of prognostic-related UPP1 tumor cells. These cells, primarily situated at the invasive front of tumors, display a stronger association with the immunosuppressive components in the TME. Our cytokine array analysis reveals that the upregulation of UPP1 in tumor cells leads to the increased release of various immunosuppressive cytokines, with TGF-β1 being particularly prominent. Furthermore, this UPP1 upregulation also elevates the expression of PD-L1 through the PI3K/AKT/mTOR pathway, which contributes to the suppression of CD8 + T cells. Cytometry by time-of-flight (CyTOF) analysis provides additional evidence of the role of UPP1 in shaping the immunosuppressive nature of the TME. Using patient-derived organoids (PDOs), we discover that UPP1 tumors exhibit relatively increased sensitivity to Bosutinib and Dasatinib. Collectively, our study highlights the immunosuppressive role of UPP1 in LUAD, and these findings may provide insights into the molecular features of LUAD and facilitate the development of personalized treatment strategies.
肿瘤微环境(TME)的复杂性是肺腺癌(LUAD)进展的关键因素。为了更深入地了解 LUAD 的分子机制,我们对 117 名 LUAD 患者样本中的 377,574 个细胞进行了综合单细胞 RNA 测序(scRNA-seq)数据分析。通过将 scRNA-seq 数据与批量基因表达数据相关联,我们确定了与 LUAD 预后相关的 UPP1 肿瘤细胞簇。这些细胞主要位于肿瘤的侵袭前沿,与 TME 中的免疫抑制成分有更强的关联。我们的细胞因子阵列分析表明,肿瘤细胞中 UPP1 的上调导致各种免疫抑制细胞因子的释放增加,其中 TGF-β1 尤为突出。此外,这种 UPP1 的上调还通过 PI3K/AKT/mTOR 通路增加了 PD-L1 的表达,从而抑制了 CD8+T 细胞。飞行时间(CyTOF)分析的细胞术提供了 UPP1 在塑造 TME 免疫抑制性质中的作用的额外证据。使用患者来源的类器官(PDOs),我们发现 UPP1 肿瘤对 Bosutinib 和 Dasatinib 的敏感性相对增加。总的来说,我们的研究强调了 UPP1 在 LUAD 中的免疫抑制作用,这些发现可能为 LUAD 的分子特征提供新的见解,并有助于制定个性化的治疗策略。
BMJ Open Respir Res. 2023-12-11
Signal Transduct Target Ther. 2023-5-22